HIT

Health In Tech, Inc.
CAPPED RATING

Health In Tech, Inc. (HIT) is rated C+ (2.6/5) on Deltasharpe Prism, scored against Technology sector peers. Its strongest pillar is Growth (B); its weakest is Momentum (D-). The rating has held at C+ for 5 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.6 / 5.0
C+
Value
B-
Factor Score 3.1 / 5.0
Growth
B
Factor Score 3.3 / 5.0
Profitability
B-
Factor Score 2.9 / 5.0
Momentum
D-
Factor Score 1.0 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio -28.0
EV / EBITDA N/A
Rev Growth YoY -13.5%
Gross Margin 53.9%
Price Return 3M -47.2%
Price Return 12M -80.8%
Catalyst Signal 0.00
Market Cap $36.5M
TTM Revenue $32.8M
Price / Sales 1.1
ROE -21.9%

Historical Factor Score Progression

Held C+ for 5 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-12 B- (3.1) B (3.3) B- (2.9) D- (1.0) C+ (2.6) C+ (2.6)
2026-11-05 B- (3.1) B (3.3) B- (2.9) D- (1.1) C+ (2.6) C+ (2.6)
2026-10-29 B- (3.1) B (3.3) B- (2.9) D (1.2) C+ (2.6) C+ (2.6)
2026-10-22 B- (3.1) B (3.3) B- (2.9) D- (0.9) C+ (2.5) C+ (2.5)
2026-10-15 B- (3.0) B (3.3) B- (2.9) D- (1.1) C+ (2.6) C+ (2.6)
Page 1 of 4